Vertex Pharmaceuticals Inc / Ma

Connor, Clark & Lunn Investment Management Ltd. VRTX

Report date

3/31/2026

Quarter

2026 Q1

Filed

5/11/2026

Shares

251,711

Value ($000)

112,399

Weight

0.3%

2014 Q1 - 2026 Q1 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	5/11/2026	112,399	0.3%	251,711	3/31/2026
2025 Q4	2/10/2026	156,583	0.4%	345,383	12/31/2025
2025 Q3	11/13/2025	86,475	0.3%	220,801	9/30/2025
2025 Q2	8/7/2025	91,753	0.3%	206,095	6/30/2025
2025 Q1	5/12/2025	7,395	0.0%	15,253	3/31/2025
2024 Q4	2/10/2025	8,458	0.0%	21,003	12/31/2024
2024 Q3	11/8/2024	3,642	0.0%	7,831	9/30/2024
2024 Q2	8/9/2024	31,585	0.1%	67,385	6/30/2024
2024 Q1	5/9/2024	49,929	0.2%	119,444	3/31/2024
2023 Q4	2/9/2024	27,831	0.1%	68,400	12/31/2023
2023 Q3	11/13/2023	1,772	0.0%	5,097	9/30/2023
2023 Q2	8/10/2023	1,372	0.0%	3,900	6/30/2023
2023 Q1	5/10/2023	1,597	0.0%	5,070	3/31/2023
2022 Q4	2/10/2023	3,225	0.0%	11,166	12/31/2022
2022 Q3	11/10/2022	8,233	0.1%	28,435	9/30/2022
2022 Q2	8/5/2022	16,823	0.1%	59,701	6/30/2022
2022 Q1	5/12/2022	7,878	0.0%	30,188	3/31/2022
2021 Q4	2/10/2022	4,882	0.0%	22,233	12/31/2021
2021 Q3	11/12/2021	4,482	0.0%	24,709	9/30/2021
2021 Q2	8/12/2021	3,720	0.0%	18,452	6/30/2021
2021 Q1	5/13/2021	4,765	0.0%	22,174	3/31/2021
2020 Q4	2/16/2021	6,024	0.0%	25,488	12/31/2020
2020 Q3	11/12/2020	14,492	0.1%	53,255	9/30/2020
2020 Q2	8/13/2020	26,607	0.2%	91,651	6/30/2020
2020 Q1	5/13/2020	23,097	0.2%	97,068	3/31/2020
2019 Q4	2/12/2020	11,239	0.1%	51,333	12/31/2019
2014 Q1	5/14/2014	17,806	0.1%	228,110	3/31/2014